Nde Pharmaceutical Private Limited
About Nde Pharmaceutical Private Limited
Data last updated:
Nde Pharmaceutical Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U85100MP2018PTC047095. Its GSTIN is 23AAGCN2913E1ZX (Madhya Pradesh).
The company has an authorised share capital of ₹9.5 Lakh and a paid-up capital of ₹2 Lakh. It was formerly known as Nandishwer Pharmaceuticals Private Limited. It is led by directors Sita Lodhi and Pooja Vishwkarma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Awadh Narayan House Number 3691 Near Ramleela Maidan Misrod, Bhopal, Madhya Pradesh, India – 462046.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.6 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net profit of ₹30,558 (net margin 1.7%) and EBITDA of ₹2.76 Lakh (EBITDA margin 15.7%). Revenue has grown at a compounded annual rate (CAGR) of 20% over five years.
The company is associated with 1 brand: NDE Pharmaceutical. As per MCA filings, the company has open charges of ₹25 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Awadh Narayan House Number 3691 Near Ramleela Maidan Misrod, Bhopal, Madhya Pradesh, India – 462046
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nde Pharmaceutical Private Limited
The main business activity of Nde Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nde Pharmaceutical Private Limited FY 2025 filings available
Nde Pharmaceutical Private Limited reported revenue of ₹17.6 Lakh (down 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Nde Pharmaceutical Private Limited
Revenue fell 39% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 20%. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nde Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.76 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹30,558 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nde Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nde Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nde Pharmaceutical Private Limited
Nde Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| D D S Electrical India Private Limited | ₹17.61 Lakh (FY 2025) | •••• | •••• | -61.0% | •••• | Delhi, India |
| Vijayshree Fabtex Private Limited | ₹17.6 Lakh (FY 2025) | •••• | •••• | -99.0% | •••• | Pali, Rajasthan, India |
| Mayuvachi Pharmaceuticals Private Limited | ₹17.6 Lakh (FY 2025) | •••• | •••• | 24.0% | •••• | Gwalior, Madhya Pradesh, India |
| Vasantha Communications Private Limited | ₹17.6 Lakh (FY 2023) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Gurbilling Brows & Skincare Studio Private Limited | ₹17.6 Lakh (FY 2023) | •••• | •••• | •••• | Mohali, Punjab, India | |
| Nde Pharmaceutical Private Limited this company | ₹17.6 Lakh (FY 2025) | •••• | •••• | -39.0% | •••• | Bhopal, Madhya Pradesh, India |
| Advik Textiles and Realpro Private Limited | ₹17.6 Lakh (FY 2024) | •••• | •••• | -50.0% | •••• | Mumbai, Maharashtra, India |
| Zerich Pharma Private Limited | ₹17.6 Lakh (FY 2024) | •••• | •••• | -2.0% | •••• | New Delhi, Delhi, India |
| Everline Healthcare Private Limited | ₹17.6 Lakh (FY 2022) | •••• | •••• | •••• | Ambala, Haryana, India | |
| Himnoor Udyog Private Limited | ₹17.59 Lakh (FY 2025) | •••• | •••• | -53.0% | •••• | Rakkar Balla, Himachal Pradesh, India |
| Japonica Merchants Private Limited | ₹17.59 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Nde Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Nde Pharmaceutical Private Limited
Nde Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sita Lodhi | Director | 20 Nov 2018 | 7 Years 10 Months | Current |
| Pooja Vishwkarma | Director | 20 Nov 2018 | 7 Years 10 Months | Current |
Ownership and Shareholding of Nde Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nde Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2023 | Others | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Associated Brands with Nde Pharmaceutical Private Limited
Nde Pharmaceutical operates one associated brand: NDE Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations for healthcare, focusing on affordable medicines and innovation. | ndepharma.com |
Employees and EPFO Compliance at Nde Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Nde Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nde Pharmaceutical Private Limited
Nde Pharmaceutical Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Pooja Vishwkarma was appointed as Director on 20 Nov 2018.
Credit Ratings, Litigation & Regulatory Alerts for Nde Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nde Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nde Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nde Pharmaceutical Private Limited
Nde Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAGCN2913E1ZX | Madhya Pradesh | Active | 08 Jul 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nde Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nde Pharmaceutical Private Limited
Nde Pharmaceutical is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 November 2018 (8+ years old) and is registered under CIN U85100MP2018PTC047095.
Nde Pharmaceutical reported revenue of ₹17.6 Lakh for FY 2025 (down 39% YoY).
Nde Pharmaceutical has 2 current directors:
- Sita Lodhi - Director
- Pooja Vishwkarma - Director
Nde Pharmaceutical reported a net profit of ₹30,558 (net margin 1.7%) and EBITDA of ₹2.76 Lakh (EBITDA margin 15.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nde Pharmaceutical is 20% over five years. In the latest year (FY 2025) revenue fell 39%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nde Pharmaceutical is 23AAGCN2913E1ZX, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Nde Pharmaceutical is U85100MP2018PTC047095. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nde Pharmaceutical was incorporated on 20 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Nde Pharmaceutical by revenue are D D S Electrical India Private Limited, Vijayshree Fabtex Private Limited, Mayuvachi Pharmaceuticals Private Limited, Vasantha Communications Private Limited, Gurbilling Brows & Skincare Studio Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Pooja Vishwkarma was appointed as Director on 20 Nov 2018. Sita Lodhi was appointed as Director on 20 Nov 2018.
The registered office of Nde Pharmaceutical is at CO Awadh Narayan House Number 3691 Near Ramleela Maidan Misrod, Bhopal, Madhya Pradesh, India – 462046.